✨ Your Portfolio is fetched and updated from zerodha.
Pharmaceuticals
Market Cap
₹0 Cr.
P/E
0.00

Key Ratios

Market cap
Market cap
-
PE
PE
-
Prom Holding
Prom Holding
-
ROE (%)
ROE (%)
23.46
ROCE (%)
ROCE (%)
27.51
Div Yield (%)
Div Yield (%)
-
Sales
Sales
43.11 Cr
OPM (%)
OPM (%)
-
Debt to Equity
Debt to Equity
0.31

About

Earkart Ltd. manufactures and distributes modern hearing aids, and trades in hearing aid parts… Read more
Low
52W Range
High

Insufficient data

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statement

New
Edit rows

Forensics

0 Yes

Positive for this company

0 Neutral

Neutral for this company

0 No

Negative for this company

0 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Customer Wise Break-Up

Peer Comparison

FAQs on Earkart Ltd. Business

Earkart assembles, manufactures, sells, trades, provides after sales services (including user training) and undertakes research and development of affordable hearing aids, MSIED Kits, TLM Kits & other rehabilitation products, including their components, accessories and parts thereof. The company focuses on Tier 2 and Tier 3 cities, where it aims to bridge the accessibility gap using innovative delivery models like branded kiosks and dedicated telehealth services.

Earkart major competitors are Osel Devices.
Market Cap of Earkart is ₹0 Crs.
While the median market cap of its peers are ₹1,051 Crs.

Earkart seems to be less financially stable compared to its competitors.
Altman Z score of Earkart is 0 and is ranked 6 out of its 8 competitors.

Company Filing

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
Earnings Release
Investor Presentation
Conference Call
Conference Call SummaryCon Call Summary

Discussions & Analysis

Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material